Model 4296 Left Ventricular (LV) Lead Chronic Performance Study

Completed

Conditions studied: Heart Failure

In brief

Lead survivability will be summarized.

Key facts

Study ID

NCT01361672

Run by

Medtronic

People needed

1140

Starts

2011-05-01

Expected to finish

2019-07-01

Last updated by the study team

2019-07-22

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
• Patient has or is intended to receive an Attain Ability Model 4296 LV lead
• Patient within 30 day post implant enrollment window

You may not qualify if…

• Patient who is, or is expected to be inaccessible for follow-up
• Patient with exclusion criteria required by local law
• Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results

Where it is running

• Study site — Anchorage, Alaska, United States
• Study site — Chandler, Arizona, United States
• Study site — Gilbert, Arizona, United States
• Study site — Phoenix, Arizona, United States
• Study site — Jonesboro, Arkansas, United States
• Study site — Little Rock, Arkansas, United States
• Study site — Bakersfield, California, United States
• Study site — Chula Vista, California, United States
• Study site — Monterey, California, United States
• Study site — Rancho Mirage, California, United States
• Study site — Redding, California, United States
• Study site — Redwood City, California, United States
• Study site — Salinas, California, United States
• Study site — San Diego, California, United States
• Study site — San Francisco, California, United States
• Study site — Stanford, California, United States
• Study site — Torrance, California, United States
• Study site — Van Nuys, California, United States
• Study site — Colorado Springs, Colorado, United States
• Study site — Lakewood, Colorado, United States
• Study site — New Haven, Connecticut, United States
• Study site — Newark, Delaware, United States
• Study site — Washington D.C., District of Columbia, United States
• Study site — Bradenton, Florida, United States
• Study site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.